Carysil Limited Q2 FY27 Revenue Rises 14.6% to ₹275.7 Crore

Carysil Limited reported Q2 FY27 consolidated revenue of ₹275.7 crore, a 14.6% year-on-year increase, while EBITDA rose to ₹54.1 crore and the EBITDA margin stood at 19.4%. The September-quarter update gives investors a current view of Carysil's sales growth, profitability and planned capacity additions through FY27.

What did Carysil report for Q2 FY27?

Carysil reported consolidated revenue of ₹275.7 crore for Q2 FY27, compared with the corresponding prior-year period, representing growth of 14.6%. Consolidated EBITDA was ₹54.1 crore, translating into an EBITDA margin of 19.4%. Profit after tax after minority interest was ₹28.4 crore, up 4.3% year-on-year.

The results were released alongside the company's unaudited financial disclosures for the quarter and half year ended September 30, 2026. The board considered and approved the standalone and consolidated Q2 and H1 FY27 results on November 4, 2026. Carysil had informed BSE about this board meeting on October 19.

The revenue increase indicates that sales expanded during the quarter, while the stated margin provides the key measure of operating profitability in the investor presentation. The more moderate growth in profit after tax after minority interest compared with revenue is also relevant when investors assess how operating performance translated into earnings attributable after minority interest.

Why do some reported Carysil figures differ from the presentation?

The figures differ because the supplied material refers to both consolidated presentation data and separate standalone results summaries. The investor presentation highlights consolidated Q2 FY27 revenue of ₹275.7 crore, whereas a separate results summary cited standalone revenue of ₹130.63 crore for the quarter ended September 30, 2026.

That standalone summary also cited EBITDA of ₹29.93 crore, an operating margin of 28.7%, and profit after tax of ₹9.96 crore. These numbers should not be directly compared with the consolidated presentation figures because they represent different reporting scopes and profit measures. Carysil's filings cover both standalone and consolidated financial statements.

The distinction matters for shareholders because consolidated accounts include the financial performance of subsidiaries, while standalone accounts report the parent company's results. Investors reviewing quarter-on-quarter or year-on-year trends need to maintain the same reporting basis throughout a comparison rather than combining metrics from the two sets of accounts.

What is Carysil's growth plan after the September quarter?

Carysil has guided for 15% growth and stated that its capacity expansions remain on track for completion by the end of FY27. The company did not provide a further numerical breakdown of the guided growth in the supplied information, so the statement should be considered alongside the reported quarterly revenue increase rather than as a detailed earnings forecast.

Capacity addition is a significant operational item for a manufacturer because it can determine the volume available to serve future demand. Carysil's earlier investor material identified quartz and stainless-steel sinks as contributors to growth, while also describing Smart Kitchen and Built-in Appliances as an emerging Indian market growth category. Those earlier comments provide context for the ongoing expansion programme.

The company has scheduled an earnings call on November 5, 2026, at 4:00 PM IST to discuss Q2 and H1 FY27 operational and financial performance. Management's explanations on the call may provide more information on execution of the expansion programme, sales trends and the basis for its 15% growth guidance. A call transcript is expected to be published on the company website.

What other corporate development did Carysil disclose?

Carysil disclosed the resignation of Executive Director and Group Chief Financial Officer Anand H. Sharma, effective November 16, 2026. The company said the resignation was due to relocation constraints and confirmed that there were no material reasons beyond the personal reasons stated.

The board took note of the change and said that further intimations would be issued when applicable. The supplied results information also states that the auditor's limited review did not identify material misstatements in the financial disclosures. This is relevant to investors because the finance leadership transition coincides with the release of the September-quarter results.

The scheduled call will therefore be an opportunity for shareholders to follow the reported operating results and listen for any company communication on the transition. No replacement for the Group CFO was identified in the provided material, and no additional details on the transition process were disclosed.

How do the Q2 FY27 disclosures affect investors and operations?

The disclosures give investors reported data on Carysil's consolidated sales, operating profit and profit after minority interest, but the supplied material does not state any share-price movement following the announcement. As a result, the available information supports an assessment of reported performance rather than a conclusion about the market's immediate reaction.

For operations, the central disclosed factors are the 15% growth guidance and the target to complete capacity expansions by the end of FY27. Revenue growth of 14.6% in Q2 FY27 and the 19.4% consolidated EBITDA margin form the current financial base against which investors can monitor future updates.

The separate standalone and consolidated numbers require particular care in investor analysis. Comparing like-for-like measures is important because the two reporting scopes can produce materially different revenue, margin and profit figures. The company has made both forms of financial results part of its regulatory reporting for the September-ended quarter.

Conclusion

Carysil's Q2 FY27 update reported consolidated revenue of ₹275.7 crore, up 14.6%, alongside EBITDA of ₹54.1 crore at a 19.4% margin and PAT after minority interest of ₹28.4 crore. The results also contained a separate set of standalone figures, making the choice of reporting basis important for any financial comparison.

The next disclosed event is Carysil's November 5 earnings call, where management is expected to discuss Q2 and H1 FY27 performance. Investors will also watch progress towards end-FY27 completion of capacity expansions, the company's 15% growth guidance and any further disclosure on the Group CFO transition.